Imatinib mesylate treatment in Philadelphia chromosome positive (PH) lekemia of childhood (2005)
Source: Pediatric Blood and Cancer. Conference titles: Annual Conference of the International Society of Paediatric Oncology. Unidade: FMRP
ABNT
OLIVEIRA, E. Morato de et al. Imatinib mesylate treatment in Philadelphia chromosome positive (PH) lekemia of childhood. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 18 abr. 2024. , 2005APA
Oliveira, E. M. de, Oliveira, F. M. de, Scrideli, C. A., Biojone, E., Queiroz, R. P., Valera, E. T. V., & Tone, L. G. (2005). Imatinib mesylate treatment in Philadelphia chromosome positive (PH) lekemia of childhood. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Oliveira EM de, Oliveira FM de, Scrideli CA, Biojone E, Queiroz RP, Valera ETV, Tone LG. Imatinib mesylate treatment in Philadelphia chromosome positive (PH) lekemia of childhood. Pediatric Blood and Cancer. 2005 ; 45( 4): 426.[citado 2024 abr. 18 ]Vancouver
Oliveira EM de, Oliveira FM de, Scrideli CA, Biojone E, Queiroz RP, Valera ETV, Tone LG. Imatinib mesylate treatment in Philadelphia chromosome positive (PH) lekemia of childhood. Pediatric Blood and Cancer. 2005 ; 45( 4): 426.[citado 2024 abr. 18 ]